ReviewJournal of biomedical science2026
Tubulin glutamylation: a key regulator of flagella, cilia, centrosomes, and disease pathways.
Review in Journal of biomedical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Tubulin glutamylation is an essential post-translational modification that expands the functional diversity of microtubules in many cellular structures, including flagella, motile cilia, primary cilia, centrosomes, and neurons. This modification adds variable lengths of glutamate side chains to the C-terminal tails of tubulin, creating a finely tuned biochemical signal that regulates microtubule stability, motor protein movement, the activity of severing enzymes, and the recruitment of key signaling molecules. Growing evidence shows that glutamylation is not uniformly distributed but instead forms distinct spatial patterns along microtubule arrays, particularly within the axonemes of flagella and cilia, centriolar triplets, and long-lived neuronal microtubules. These patterns are established by tubulin ligase-like enzymes that add glutamates and by carboxypeptidases that remove them, together shaping a dynamic "tubulin code." In motile cilia and flagella, glutamylation fine-tunes dynein-driven force generation and the coordination of axonemal bending. Disruption of this modification impairs ciliary beating and sperm flagellar motility, leading to disorders such as primary ciliary dyskinesia, which manifests as chronic respiratory infections and laterality defects, and can also disrupt cerebrospinal fluid flow, causing hydrocephalus and male infertility such as asthenozoospermia. In primary cilia, reduced glutamylation perturbs intraflagellar transport and ciliary signaling and contributes to ciliopathies including Joubert syndrome and retinal degeneration. In dividing cells, altered glutamylation on centrosomes leads to errors in chromosome segregation and is associated with cancer progression. This review summarizes current knowledge of the enzymes, structural principles, and cellular mechanisms governing tubulin glutamylation, highlights its emerging roles in human diseases, and discusses new technological advances-including biochemical reconstitution, super-resolution imaging, and live-cell manipulation tools-that are beginning to reveal how this modification dynamically controls microtubule properties and the functions of flagella, cilia, and centrosomes in health and disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.